Ravi Chari
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 46
- HER2/EGFR in Cancer Research 44
-
- Monoclonal and Polyclonal Antibodies Research 42
- Radiopharmaceutical Chemistry and Applications 10
- Co-authors
- Wayne C. Widdison (20 shared papers)John M. Lambert (11 shared papers)Michael L. Miller (23 shared papers)Beverly A. Teicher (1 shared paper)Robert J. Lutz (5 shared papers)Victor S. Goldmacher (15 shared papers)Walter A. Blättler (3 shared papers)Yelena Kovtun (19 shared papers)
- Journals
- Cancer Research (13 papers)Molecular Cancer Therapeutics (10 papers)Journal of Medicinal Chemistry (7 papers)Journal of the American Chemical Society (5 papers)Molecular Pharmaceutics (4 papers)
- Partner nations
- United StatesGreeceUnited Kingdom
In The Last Decade
Ravi Chari
73 papers receiving 6.1k citations
Ravi Chari's Hit Papers
Peers
Comparison fields: 5 of 119
- Radiology, Nuclear Medicine and Imaging 3.1k
- Oncology 3.5k
- Molecular Biology 2.5k
- Immunology and Allergy 188
- Biomaterials 403
Countries citing papers authored by Ravi Chari
This map shows the geographic impact of Ravi Chari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Chari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Chari more than expected).
Fields of papers citing papers by Ravi Chari
This network shows the impact of papers produced by Ravi Chari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Chari. The network helps show where Ravi Chari may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravi Chari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate Hit paper breakdown → | 2008 | 1273 |
| 2 | Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy Hit paper breakdown → | 2014 | 766 |
| 3 | Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs Hit paper breakdown → | 2007 | 643 |
| 4 | Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer Hit paper breakdown → | 2014 | 403 |
| 5 | 2011 | 330 | |
| 6 | 2006 | 233 | |
| 7 | 2010 | 199 | |
| 8 | 1998 | 181 | |
| 9 | 2010 | 173 | |
| 10 | 2011 | 154 | |
| 11 | 2011 | 154 | |
| 12 | 2003 | 146 | |
| 13 | 2009 | 136 | |
| 14 | 2018 | 132 | |
| 15 | 2010 | 131 | |
| 16 | 1997 | 105 | |
| 17 | 1984 | 76 | |
| 18 | 2007 | 67 | |
| 19 | 2011 | 66 | |
| 20 | 2016 | 65 |
About Ravi Chari
Ravi Chari is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Organic Chemistry and Cell Biology, having authored 76 papers that have together received 6.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (44 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), Cancer therapeutics and mechanisms (10 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Click Chemistry and Applications (6 papers), Advanced Biosensing Techniques and Applications (5 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.1k citations), Oncology (3.5k citations), Molecular Biology (2.5k citations), Immunology and Allergy (188 citations) and Biomaterials (403 citations). Ravi Chari has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Wayne C. Widdison, John M. Lambert, Michael L. Miller, Beverly A. Teicher, Robert J. Lutz, Victor S. Goldmacher, Walter A. Blättler, Yelena Kovtun, Sharon Wilhelm and Kathryn L. Parsons. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, Journal of the American Chemical Society and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.